These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17287073)

  • 1. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
    Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.
    Dassoulas K; Gazouli M; Rizos S; Theodoropoulos G; Christoni Z; Nikiteas N; Karakitsos P
    Mol Carcinog; 2009 Jun; 48(6):563-9. PubMed ID: 19009560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival.
    Tzanakis N; Gazouli M; Rallis G; Giannopoulos G; Papaconstantinou I; Theodoropoulos G; Pikoulis E; Tsigris C; Karakitsos P; Peros G; Nikiteas N
    J Surg Oncol; 2006 Dec; 94(7):624-30. PubMed ID: 17111394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
    Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
    Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
    Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
    Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial Comment on: Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Staehler M
    Eur Urol; 2007 Oct; 52(4):1155. PubMed ID: 17287072
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
    Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
    Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
    Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
    Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
    Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.
    Hefler LA; Mustea A; Könsgen D; Concin N; Tanner B; Strick R; Heinze G; Grimm C; Schuster E; Tempfer C; Reinthaller A; Zeillinger R
    Clin Cancer Res; 2007 Feb; 13(3):898-901. PubMed ID: 17289883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients.
    Yang YQ; Chen J
    Genet Mol Res; 2014 Jul; 13(3):5011-7. PubMed ID: 25062489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.
    Sfar S; Hassen E; Saad H; Mosbah F; Chouchane L
    Cytokine; 2006 Jul; 35(1-2):21-8. PubMed ID: 16908180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.
    Hirata H; Hinoda Y; Nakajima K; Kikuno N; Suehiro Y; Tabatabai ZL; Ishii N; Dahiya R
    J Urol; 2009 Aug; 182(2):721-7. PubMed ID: 19539330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma.
    Bruyère F; Hovens CM; Marson MN; d'Arcier BF; Costello AJ; Watier H; Linassier C; Ohresser M
    J Urol; 2010 Oct; 184(4):1273-8. PubMed ID: 20723915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
    Rivet J; Mourah S; Murata H; Mounier N; Pisonero H; Mongiat-Artus P; Teillac P; Calvo F; Janin A; Dosquet C
    Cancer; 2008 Jan; 112(2):433-42. PubMed ID: 18041056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.
    Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F
    Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis.
    Kang S; Zhao J; Liu Q; Zhou R; Wang N; Li Y
    Environ Mol Mutagen; 2009 Jun; 50(5):361-6. PubMed ID: 19197986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
    Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
    BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.